SCHEMBL8842

SCHEMBL8842

Nc1ncnc2c1ncn2CCc1oc2ccccc2c(=O)c1-c1cc(F)cc(F)c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 5/20 0.47
▸ NSD3 Q9BZ95 8/20 0.47
▸ NSD2 O96028 7/20 0.47
▸ LMNA P02545 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ EGFR P00533 3/20 0.41
▸ ERBB2 P04626 1/20 0.40
▸ BRAF P15056 1/20 0.40
▸ KDR P35968 1/20 0.40
▸ TEK Q02763 1/20 0.40
▸ AURKB Q96GD4 1/20 0.40
▸ PI4KA P42356 1/20 0.40
▸ PI4K2B Q8TCG2 1/20 0.40
▸ PI4K2A Q9BTU6 1/20 0.40
▸ PI4KB Q9UBF8 1/20 0.40
▸ ADORA1 P30542 2/20 0.39
▸ ADORA2B P29275 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8575 0.93 ADORA2A (0.46) ADORA2ANSD3NSD2LMNASMN1; SMN2
SCHEMBL8117 0.93 ADORA2A (0.49) ADORA2ANSD3NSD2LMNASMN1; SMN2
SCHEMBL15688607 0.90 ADORA2A (0.55) ADORA2ANSD3NSD2LMNASMN1; SMN2
SCHEMBL8598 0.88 ADORA2A (0.51) ADORA2ANSD3NSD2LMNASMN1; SMN2
SCHEMBL8993 0.88 NSD2 (0.44) ADORA2ANSD3NSD2LMNASMN1; SMN2
SCHEMBL8770 0.88 NSD2 (0.47) ADORA2ANSD3NSD2LMNASMN1; SMN2
SCHEMBL9275 0.88 NSD2 (0.47) ADORA2ANSD3NSD2LMNASMN1; SMN2
SCHEMBL15689097 0.86 ADORA2A (0.48) ADORA2ANSD3NSD2LMNASMN1; SMN2
SCHEMBL9569 0.84 ADORA2A (0.50) ADORA2ANSD3NSD2LMNASMN1; SMN2
SCHEMBL30013691 0.84 PIK3CD (0.46) ADORA2ANSD3NSD2LMNAPI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2496567-A2 NOVEL BENZOPYRAN KINASE MODULATORS Rhizen Pharmaceuticals S.A. (CH) 2012-09-12 — — EP claimed
WO-2011055215-A2 NOVEL KINASE MODULATORS INCOZEN THERAPEUTICS PVT. LTD. (IN) 2011-05-12 — — WO claimed
EP-4292596-A1 METHOD AND COMBINATION FOR TREATING TUMORS Curon Biopharmaceutical (Shanghai) Co., Limited (CN) 2023-12-20 — — EP disclosed
EP-2916868-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING A PDE4 INHIBITOR AND A PI3 DELTA OR DUAL PI3 DELTA-GAMMA KINASE INHIBITOR Rhizen Pharmaceuticals S.A. (CH) 2015-09-16 — — EP disclosed
WO-2014072937-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING A PDE4 INHIBITOR AND A PI3 DELTA OR DUAL PI3 DELTA-GAMMA KINASE INHIBITOR RHIZEN PHARMACEUTICALS SA (CH) 2014-05-15 — — WO disclosed
EP-2496567-A2 NOVEL BENZOPYRAN KINASE MODULATORS Rhizen Pharmaceuticals S.A. (CH) 2012-09-12 — — EP disclosed
WO-2011055215-A2 NOVEL KINASE MODULATORS INCOZEN THERAPEUTICS PVT. LTD. (IN) 2011-05-12 — — WO disclosed
Send feedback